Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

AbstractAboutThe 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Pulmonary Hypertension

  Free Subscription


10.11.2025

1 Am J Cardiovasc Drugs
1 Anatol J Cardiol
1 Biochem Pharmacol
1 Br J Pharmacol
1 Can Respir J
1 Cell Prolif
1 Curr Med Sci
2 Eur Heart J Qual Care Clin Outcomes
1 Eur J Pharmacol
2 Eur Respir J
1 Expert Opin Drug Saf
1 Eye (Lond)
1 Front Med (Lausanne)
1 Intensive Care Med Exp
1 J Am Heart Assoc
1 J Am Soc Echocardiogr
1 J Cardiovasc Pharmacol
1 J Dermatol
1 Medicine (Baltimore)
1 Minerva Gastroenterol (Torino)
1 Monaldi Arch Chest Dis
1 Pulm Circ
1 Respiration
1 Respirology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiovasc Drugs

  1. VILELA APO, Deffert F, Tonin FS, Pontarolo R, et al
    Overview of Systematic Reviews on Treatments for Pulmonary Arterial Hypertension: Assessing Methodological Quality and Mapping Evidence Gaps.
    Am J Cardiovasc Drugs. 2025;25:779-802.
    PubMed         Abstract available


    Anatol J Cardiol

  2. EROL C
    Consensus Report on Pulmonary Hypertension, Gut Microbiota, Postural Orthostatic Tachycardia Syndrome....
    Anatol J Cardiol. 2025;29:598.
    PubMed        


    Biochem Pharmacol

  3. CHOU YH, Lee YN, Wu SH, Su CH, et al
    Deciphering endothelial aldehyde dehydrogenase 2, oxidative stress, and interleukin-6 interactions in pulmonary hypertension: Implications for precision medicine.
    Biochem Pharmacol. 2025 Oct 31:117510. doi: 10.1016/j.bcp.2025.117510.
    PubMed         Abstract available


    Br J Pharmacol

  4. LANDY C, De Blasio MJ, Woodman OL, Maffia P, et al
    Resolution of inflammation in pulmonary arterial hypertension, the influence of sex-An IUPHAR immunopharmacology committee review.
    Br J Pharmacol. 2025;182:5706-5733.
    PubMed         Abstract available


    Can Respir J

  5. QI Y, Liu J, Cui X, Wang Y, et al
    The Diagnostic Value of Transthoracic Echocardiography Parameters Under the New Diagnostic Criteria for Pulmonary Hypertension.
    Can Respir J. 2025;2025:2592204.
    PubMed         Abstract available


    Cell Prolif

  6. LI S, Zhang J, Wang X, Wang X, et al
    Super-Enhancer Target Gene CBP/p300-Interacting Transactivator With Glu/Asp-Rich C-Terminal Domain, 2 Cooperates With Transcription Factor Forkhead Box J3 to Inhibit Pulmonary Vascular Remodeling.
    Cell Prolif. 2025;58:e13817.
    PubMed         Abstract available


    Curr Med Sci

  7. YU LL, Jiang DS, Wang X, Fang ZM, et al
    Global, Regional, and National Burden of Pulmonary Arterial Hypertension from 1990 to 2021 and Projections to 2040: A Systematic Analysis of Incidence, Mortality, and Disability-Adjusted Life Years.
    Curr Med Sci. 2025;45:1068-1078.
    PubMed         Abstract available


    Eur Heart J Qual Care Clin Outcomes

  8. MALI RMA, Ninaber MK, van Mens TE, Konstantinides SV, et al
    Key elements of follow-up care after acute pulmonary embolism focusing on long-term sequelae: a Delphi study among European experts.
    Eur Heart J Qual Care Clin Outcomes. 2025;11:1137-1143.
    PubMed         Abstract available

  9. LIU K, Zeng Y, Wang H, Yang H, et al
    Global, regional, and national burden of pulmonary arterial hypertension and related heart failure from 1990 to 2021, with predictions to 2050: insights from the global burden of disease study 2021.
    Eur Heart J Qual Care Clin Outcomes. 2025;11:969-980.
    PubMed         Abstract available


    Eur J Pharmacol

  10. BAI Y, Jiang Y, Zhou Y, Xia Y, et al
    The Role of Ferroptosis in the Pathogenesis of Pulmonary Hypertension and Its Therapeutic Potential.
    Eur J Pharmacol. 2025 Nov 1:178316. doi: 10.1016/j.ejphar.2025.178316.
    PubMed         Abstract available


    Eur Respir J

  11. JEVNIKAR M, Brenot P, Kularatne M, Rodiere A, et al
    Chronic thromboembolic pulmonary hypertension associated with venous thoracic outlet syndrome: a retrospective case series.
    Eur Respir J. 2025 Nov 6:2501610. doi: 10.1183/13993003.01610-2025.
    PubMed        

  12. OSORIO J, Tura-Ceide O, Pavia J, Vollmer I, et al
    Increased lung [(18)F]-FDG uptake in chronic thromboembolic pulmonary hypertension with distal involvement.
    Eur Respir J. 2025 Nov 6:2500130. doi: 10.1183/13993003.00130-2025.
    PubMed        


    Expert Opin Drug Saf

  13. CHAI S, Xu H, Xu G, Cai C, et al
    ORENITRAM's decadal journey: unveiling safety profiles and adverse event through a real-world pharmacovigilance study of FAERS events.
    Expert Opin Drug Saf. 2025;24:1265-1280.
    PubMed         Abstract available


    Eye (Lond)

  14. EILON E, Lishinsky-Fischer N, Levy J
    Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study.
    Eye (Lond). 2025 Nov 4. doi: 10.1038/s41433-025-04093.
    PubMed         Abstract available


    Front Med (Lausanne)

  15. WAN CY, Liu YX, Gong SG, Zhao QH, et al
    Non-invasive PECS model for detection of combined post-capillary pulmonary hypertension.
    Front Med (Lausanne). 2025;12:1660387.
    PubMed         Abstract available


    Intensive Care Med Exp

  16. WANG D, Hu S, Cao J, Fan H, et al
    Establishment of a neonatal rat model of sequential hyperoxic hypoxia to recapitulate clinical progression of bronchopulmonary dysplasia-associated pulmonary hypertension.
    Intensive Care Med Exp. 2025;13:112.
    PubMed         Abstract available


    J Am Heart Assoc

  17. UHLAND C, Gibbs A, Insel M, Kubba S, et al
    Treatment Response and Survival in Methamphetamine-Associated Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2025;14:e042673.
    PubMed         Abstract available


    J Am Soc Echocardiogr

  18. OSGUERITCHIAN R, Jani VP, Mombeini H, Gami A, et al
    Refining Risk Prediction in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    J Am Soc Echocardiogr. 2025;38:1064-1074.
    PubMed         Abstract available


    J Cardiovasc Pharmacol

  19. ZHANG H, Ren J, He Y, Zhao K, et al
    GPX4: A Key Regulator of Mitochondrial Function and Glycolysis in Pulmonary Artery Smooth Muscle Cells.
    J Cardiovasc Pharmacol. 2025;86:489-497.
    PubMed         Abstract available


    J Dermatol

  20. MOCHIZUKI R, Miyazaki R, Nakatani S, Takai T, et al
    Pulmonary Tumor Thrombotic Microangiopathy Secondary to Extramammary Paget's Disease: An Autopsy Case Report.
    J Dermatol. 2025;52:1727-1731.
    PubMed         Abstract available


    Medicine (Baltimore)

  21. PAN YS, Xu GR, Qu NN, Qin YB, et al
    Exploration of upstream and downstream mechanisms of the TAGLN2 gene in pulmonary arterial hypertension.
    Medicine (Baltimore). 2025;104:e45295.
    PubMed         Abstract available


    Minerva Gastroenterol (Torino)

  22. SIUBA MT, Abushamma A, Qureshi A, Ivary S, et al
    Impact of medical therapy on liver transplant eligibility in patients with portopulmonary hypertension: a systematic review.
    Minerva Gastroenterol (Torino). 2025;71:289-294.
    PubMed         Abstract available


    Monaldi Arch Chest Dis

  23. LANDI I, Alharbil S, Alfehaid A, Aldosari S, et al
    Clinical and echocardiographic predictors of outcome in liver transplant patients.
    Monaldi Arch Chest Dis. 2025;95.
    PubMed         Abstract available


    Pulm Circ

  24. HAN P, Ma R, Xie W, Li H, et al
    The Predictive Value of Quantitative Analysis of SPECT V/Q Imaging for Postoperative Persistent/Recurrent Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy.
    Pulm Circ. 2025;15:e70195.
    PubMed         Abstract available


    Respiration

  25. BENJAMIN N, Resag C, Xanthouli P, Harutyunova S, et al
    Fluid Restriction in Patients with Pulmonary Arterial Hypertension and Right Heart Failure.
    Respiration. 2025;104:800-813.
    PubMed         Abstract available


    Respirology

  26. DURRINGTON C, Battersby C, Holt L, Fairman A, et al
    NT-proBNP and BNP Testing in Pulmonary Arterial Hypertension: Point-of-Care and Remote Monitoring.
    Respirology. 2025;30:1094-1103.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.